Microba receives ISO15189 accreditation for untargeted metagenomic assay of stool samples, unlocking diagnostic applications of the microbiome.
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Leading Australian universities will explore the ‘cognobiome’ of soldiers using Microba’s analysis platform to discover opportunities for improving...
Results published in Cell show dietary restriction drives microbiome diversity changes in autistic individuals.
Dr Jean-Philippe Laine joins as US Director of Business Development to drive forward global research and discovery partnerships.
Microba will work with Anatara to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D.
Experts will present opportunities for harnessing the microbiome for innovative products, therapies and diagnostics to a global audience.
Three key opinion leaders will make much-needed advancements in treatment options for Inflammatory Bowel Disease on new advisory panel.
Precise measurement of the gut microbiome empowers new discoveries in research and the development of innovative treatments and diagnostics.
Using the NEW1000 Family Study, researchers will investigate the role of the microbiome in the developmental origins of health and disease.